Dr. Poone Shoureshi, MD

Dr. Shoureshi practices at Laguna Hills Infusion - HOPD in Laguna Hills, California.

Dr. Shoureshi's NPI, 1023472149, was assigned on April 6, 2016. Dr. Shoureshi graduated from George Washington University School of Medicine and Health Sciences in 2016. Dr. Shoureshi holds California license A172900.

Dr. Shoureshi's primary practice is Laguna Hills Infusion - HOPD, at 23961 Calle De La Magdalena, Laguna Hills, CA 92653.

Dr. Shoureshi's primary practice is Laguna Hills Infusion - HOPD in Laguna Hills, California. Dr. Shoureshi is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is Orange County Urology Associates. Dmand AI also links Dr. Shoureshi to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Shoureshi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shoureshi practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Shoureshi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Shoureshi is board certified in urology by the American Board of Urology. Dmand AI has Dr. Shoureshi's licenses on file in 2 states: California and Oregon.

Dmand AI lists bladder disease, pelvic prolapse, urinary endoscopy and UTI among the conditions Dr. Shoureshi treats.

CMS data shows 9,565 Medicare services from Dr. Shoureshi across 28 procedure codes in 2024, for 599 Medicare patients. Medicare paid $229,835 for them.

CMS counts 599 Medicare patients who saw Dr. Shoureshi in 2024. The largest group is 75 to 84, with 286 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shoureshi's median patient age at 73, with 93% women.

In 2024, Dr. Shoureshi wrote 2,507 Medicare Part D claims for 750 patients. 68% of them were for generic drugs. CMS names the drug for 2,401 of them, across 26 drugs with 11 or more claims each, at $626,494 in total drug cost. In 2023, CMS named 654 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Shoureshi for performance year 2024, reported as part of a group. Dr. Shoureshi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shoureshi as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Shoureshi, published from 2017 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Vagina, Gender-Affirming Surgery and Gender Dysphoria. Dr. Shoureshi has published most often in Urology. Dr. Shoureshi's most frequent co-authors are Christopher Lee Amling, FACS, MD, Daniel David Dugi, MD and Karyn S. Eilber, MD.

CMS Open Payments shows 261 general payments to Dr. Shoureshi from 21 drug and device companies from 2021 to 2025. Grants make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $14,223.

Dr. Shoureshi graduated from George Washington University School of Medicine and Health Sciences in 2016.

Dr. Shoureshi is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.